Amanda Vincent

ORCID: 0000-0002-3760-7266 · 7 papers in corpus · active 1999-2020

Study types

  • article 4
  • review 3
review 2020
·doi:10.1055/s-0041-1726273

Early menopause/premature ovarian insufficiency is associated with negative health impacts, unmet information needs, delayed diagnosis, and variation in management. Co-designed digital resources for women with early menopause/premature ovar…

article 2020
·doi:10.1007/s11657-020-00713-8
review 2020
·doi:10.1055/s-0040-1722317

Premature ovarian insufficiency (POI) and early menopause, defined as loss of ovarian activity prior to 40 years or menopause between the ages of 40 and 45 years, respectively, is associated with significant adverse health impacts. Recent d…

article 2014
·doi:10.3109/09513590.2014.975682

BACKGROUND: Depression, anxiety, and inflammation are common in polycystic ovary syndrome (PCOS). Inflammation may adversely impact on mood and vitamin D has been associated with both mood disorders and inflammation in the general populatio…

review 2010
·doi:10.3109/13697137.2010.495424

Premature surgical menopause is becoming increasingly common in the setting of both benign and malignant disease. These women are at an increased risk of all-cause and cardiovascular mortality, cognitive dysfunction and metabolic bone disea…

article 2002
·doi:10.1093/humrep/17.5.1189

BACKGROUND: Abnormal uterine bleeding is commonly associated with progestin-only contraceptives, including depot medroxyprogesterone acetate (DMPA), and remains the main reason why these agents are discontinued. Matrix metalloproteinases (M…

article 1999
·doi:10.1093/humrep/14.3.807

Norplant, subdermally implanted slow-release levonorgestrel, is an effective and widely used contraceptive agent but has a high rate of discontinuation due to unacceptable abnormal uterine bleeding. Matrix metalloproteinases (MMPs) are expr…